Search

Author/Creator Jamitzky, Silke

1. Insulin‐like growth factor‐1 receptor (IGF‐1R) inhibition promotes expansion of human NK cells which maintain their potent antitumor activity against Ewing sarcoma cells. Issue 11 (1st July 2015)

Authors:
Jamitzky, Silke; Krueger, Andrea‐Caroline; Janneschuetz, Saskia; Piepke, Stephanie; Kailayangiri, Sareetha; Spurny, Christian; Rossig, Claudia; Altvater, Bianca
Journal:
Pediatric blood & cancer
Issue:
Volume 62:Issue 11(2015:Nov.)
Page Start:
1979
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Programmed cell death ligand 1 (PD‐L1) expression is not a predominant feature in Ewing sarcomas. Issue 1 (4th September 2017)

Authors:
Spurny, Christian; Kailayangiri, Sareetha; Jamitzky, Silke; Altvater, Bianca; Wardelmann, Eva; Dirksen, Uta; Hardes, Jendrik; Hartmann, Wolfgang; Rossig, Claudia
Journal:
Pediatric blood & cancer
Issue:
Volume 65:Issue 1(2018)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G. (2nd January 2017)

Authors:
Kailayangiri, Sareetha; Altvater, Bianca; Spurny, Christian; Jamitzky, Silke; Schelhaas, Sonja; Jacobs, Andreas H.; Wiek, Constanze; Roellecke, Katharina; Hanenberg, Helmut; Hartmann, Wolfgang; Wiendl, Heinz; Pankratz, Susann; Meltzer, Jutta; Farwick, Nicole; Greune, Lea; Fluegge, Maike; Rossig, ...
Journal:
Oncoimmunology
Issue:
Volume 6:Number 1(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗